Alan Fuhrman - 13 Mar 2026 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Chief Financial Officer
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Issuer symbol
TYRA
Transactions as of
13 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 16:59:04 UTC
Previous filing
17 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fuhrman Alan Chief Financial Officer C/O TYRA BIOSCIENCES, INC., 2656 STATE STREET, CARLSBAD /s/ Ali D. Fawaz, Attorney-in-Fact 17 Mar 2026 0001303521

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Award +1,376 +9.3% $9.13* 16,164 13 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.